Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2

David Yao1, Raj S Patel1, Adrien Lam1

  • 1Department of Surgery, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Insights

Researchers identified conserved viral epitopes that could be targeted for next-generation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. This strategy aims to improve broad protection against current and future coronavirus outbreaks.

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show reduced efficacy against variants of concern and offer short-lived immunity.
  • Frequent vaccine boosting may lead to immune imprinting, further complicating vaccine effectiveness.

Purpose of the Study:

  • To investigate conserved cross-reactive epitopes for developing broadly protective SARS-CoV-2 vaccines.
  • To analyze IgG antibody responses in vaccinated and unvaccinated individuals against SARS-CoV-2 variants.

Main Methods:

  • Examined IgG antibody responses in mRNA-vaccinated, AstraZeneca-vaccinated, and unvaccinated donors.
  • Assessed antibody specificity against eight different spike (S) variants.
  • Correlated antibody titers with specific epitopes on S, nucleocapsid (N), and membrane (M) proteins.

Main Results:

  • Identified cross-reactive IgG antibodies targeting eight SARS-CoV-2 spike variants.
  • Observed associations between antibody titers and spike S1/S2 subunit epitopes (P1, P2).
  • Found correlations between N/M-specific IgG titers and conserved beta-coronavirus epitopes (P3-7).

Conclusions:

  • Revealed conserved viral epitopes targeted by natural and vaccine-induced immunity.
  • Provides a foundation for designing next-generation COVID-19 vaccines with broader protective capabilities.
  • Highlights potential targets for improved SARS-CoV-2 vaccine strategies against emerging variants.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
31.0K
Vaccinations01:51

Vaccinations

Overview
44.1K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
468
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
72.2K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K